Pro-self Pain Management in Norway
Pro-self
Pro-self - a Nursing Intervention to Support and Educate Cancer Patients and Their Caregivers so That the Patient Can Stay Home
1 other identifier
interventional
167
1 country
1
Brief Summary
The main aim of this study is to evaluate whether a patient education programme on cancer pain management compared to standard care decreases pain and increases patients quality of life. The investigators hypothesis is that patients and family caregivers who receive the intervention will have improved outcomes. Patients and family members are seen in their homes by the nurses doing the intervention over 6 weeks. Patients keep a diary of their pain and medication intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Oct 2004
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 25, 2008
CompletedFirst Posted
Study publicly available on registry
September 26, 2008
CompletedMay 24, 2011
September 1, 2008
3.5 years
September 25, 2008
May 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Worst pain intensity
6 weeks
Secondary Outcomes (1)
Knowledge of cancer pain management
6 weeks
Study Arms (2)
1
EXPERIMENTALPatients who received the Pro-Self psychoeducational intervention
2
NO INTERVENTIONPatients who received standard care
Interventions
A 6 week psychoeducational programme that included three home visits and three phone calls. Patients were taught about pain medication and side effects and about incorrect information regarding cancer pain management
Eligibility Criteria
You may qualify if:
- Greater than 18 years of age
- Radiographic evidence of bone metastasis
- Able to read and write Norwegian
- Average pain intensity of greater than 2.5
You may not qualify if:
- Brain metastasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ulleval University Hospital
Oslo, Norway
Related Publications (1)
Rustoen T, Lerdal A, Gay C, Kottorp A. Rasch analysis of the Herth Hope Index in cancer patients. Health Qual Life Outcomes. 2018 Oct 3;16(1):196. doi: 10.1186/s12955-018-1025-5.
PMID: 30285767DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tone Rustoen, PhD
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 25, 2008
First Posted
September 26, 2008
Study Start
October 1, 2004
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
May 24, 2011
Record last verified: 2008-09